DocGo (NASDAQ:DCGO – Get Free Report) and IceCure Medical (NASDAQ:ICCM – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.
Earnings and Valuation
This table compares DocGo and IceCure Medical”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| DocGo | $322.20 million | 0.17 | -$182.40 million | ($1.91) | -0.29 |
| IceCure Medical | $3.38 million | 3.03 | -$15.06 million | ($7.21) | -0.50 |
Volatility and Risk
DocGo has a beta of 1, suggesting that its stock price has a similar volatility profile to the S&P 500.Comparatively, IceCure Medical has a beta of 0.4, suggesting that its stock price is 60% less volatile than the S&P 500.
Analyst Ratings
This is a summary of current ratings and target prices for DocGo and IceCure Medical, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DocGo | 1 | 2 | 3 | 0 | 2.33 |
| IceCure Medical | 1 | 1 | 3 | 0 | 2.40 |
DocGo presently has a consensus target price of $2.38, suggesting a potential upside of 335.70%. IceCure Medical has a consensus target price of $62.70, suggesting a potential upside of 1,622.53%. Given IceCure Medical’s stronger consensus rating and higher probable upside, analysts plainly believe IceCure Medical is more favorable than DocGo.
Insider & Institutional Ownership
56.4% of DocGo shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 3.8% of DocGo shares are held by insiders. Comparatively, 2.4% of IceCure Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Profitability
This table compares DocGo and IceCure Medical’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| DocGo | -62.23% | -44.09% | -29.14% |
| IceCure Medical | -441.60% | -211.73% | -119.13% |
Summary
DocGo beats IceCure Medical on 9 of the 13 factors compared between the two stocks.
About DocGo
DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.
About IceCure Medical
IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
